Related Experiment Videos
Focal hepatic ablation using interstitial photon radiation energy
L G Koniaris1, D Y Chan, C Magee
1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of the American College of Surgeons
|August 17, 2000
Summary
Point-source photon radiosurgery (PRS) effectively creates liver lesions for tumor treatment. This novel radiation therapy is well-tolerated, showing promise for hepatic malignancies.
Area of Science:
- Hepatobiliary surgery
- Radiation oncology
- Interventional radiology
Background:
- Intratumoral ablative therapy is increasingly utilized for hepatic malignancies.
- Interstitial point-source photon radiosurgery (PRS) offers a novel radiation therapy approach, similar in dosimetry to brachytherapy.
Purpose of the Study:
- To assess the feasibility, toxicity, and tissue destructive capabilities of PRS in the liver.
- To evaluate PRS in a canine model for potential application in treating liver tumors.
Main Methods:
- A 6-month survival study in a canine model using PRS.
- Two dose groups: low-dose (20 Gy at lesion edge, 2.0 cm diameter) and high-dose (20 Gy at lesion edge, 3.0 cm diameter).
- Treatments delivered to right, central, and left hepatic regions.
Main Results:
- PRS generated sharply demarcated hepatic ablative lesions proportional to dose.
- Mean lesion diameters: 1.6 cm (low-dose) and 3.4 cm (high-dose).
- Hilar damage observed with PRS on portal structures, linked to thrombosis and bile duct injury; no damage to large hepatic veins or IVC.
Conclusions:
- PRS ablation is well-tolerated, producing consistent, necrotic lesions with minimal adjacent injury.
- The technique demonstrates promise for treating liver tumors.
- Careful application is needed to avoid hilar structure damage.